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Wear debris from cobalt/chromium (Co/Cr) alloy metal-on-metal bearings in prosthetic hip 
replacements has created a significant internal source of cobalt exposure in these patients.  
Co toxicity is suspected to contribute to severe systemic adverse effects, including cardiac and 
CNS effects, in patients with high circulating Co concentrations. This study investigated the 
effects of chronic Co exposure to rats (1mg/kg i.p. CoCl2, daily, for 28 days) and Co uptake 
into primary adult rat cardiac fibroblasts (CFs). Co treatment was associated with 
accumulation into various organs of the body and significant increases in Co levels were 
detected in liver, kidney and heart. Echocardiography showed functional changes that 
correlated with compromised cardiac contractility. Fractional shortening was significantly 
reduced in CoCl2-treated rats following 28 days treatment compared to the control group 
(54.01±0.90% and 60.29±0.53% respectively), providing evidence of contractile dysfunction.  
Cellular studies examined uptake of CoCl2 into both CFs and 3T3 fibroblasts using inductively 
coupled plasma mass spectrometry (ICP-MS) to measure intracellular metal content. The 
range of Co uptake increased proportionally (0-50 µg/L) for the 3T3 cells, as well as for the 
CFs (about 0-120 µg/L) when the CoCl2 concentration in the medium was increased between 
0 and 72 mg/L. Uptake of Co into CFs was significantly greater than into 3T3 cells. The greater 
accumulation of CoCl2 into CFs suggests Co ions in vivo could accumulate in these cells, leading 
to functional consequences on cardiac performance. Future work will focus on determining 
the underlying uptake mechanism which could have important therapeutic implications. 
 
 
